Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer

NCT07630948 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adherence, Medication

Interventions

BEHAVIORAL: Adherence package consisting of additional education and adherence reminders

Sponsor

Institute of Oncology Ljubljana